Dr. Michael Heit, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $321.88 | 14 | 72.2% |
| Grant | $124.00 | 1 | 27.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $221.21 | 3 | $0 (2021) |
| Astellas Pharma US Inc | $124.36 | 7 | $0 (2017) |
| Allergan Inc. | $59.45 | 3 | $0 (2017) |
| Mission Pharmacal Company | $20.98 | 1 | $0 (2017) |
| Braintree Laboratories, Inc. | $19.88 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $19.88 | 1 | Braintree Laboratories, Inc. ($19.88) |
| 2021 | $61.06 | 1 | BOSTON SCIENTIFIC CORPORATION ($61.06) |
| 2019 | $160.15 | 2 | Boston Scientific Corporation ($160.15) |
| 2017 | $204.79 | 11 | Astellas Pharma US Inc ($124.36) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: GI COLON PREP | ||||||
| 07/13/2021 | BOSTON SCIENTIFIC CORPORATION | SOLYX (Device) | Food and Beverage | In-kind items and services | $61.06 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/26/2019 | Boston Scientific Corporation | GENERAL - FEMALE SUI (Device) | Grant | Cash or cash equivalent | $124.00 | General |
| Category: FEMALE SUI | ||||||
| 11/22/2019 | Boston Scientific Corporation | GENERAL FEMALE SUI (Device) | Food and Beverage | In-kind items and services | $36.15 | General |
| Category: FEMALE SUI | ||||||
| 11/13/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Xtandi, Vesicare | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Urology | ||||||
| 10/30/2017 | Allergan Inc. | ESTRACE CREAM (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: WOMENS HEALTH | ||||||
| 10/23/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Urology | ||||||
| 10/16/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Urology | ||||||
| 07/31/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Urology | ||||||
| 06/26/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Urology | ||||||
| 05/08/2017 | Allergan Inc. | ESTRACE CREAM (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: WOMENS HEALTH | ||||||
| 04/18/2017 | Allergan Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: WOMENS HEALTH | ||||||
| 04/17/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Urology | ||||||
| 03/24/2017 | Mission Pharmacal Company | CitraNatal (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Prenatal Vitamin & Mineral | ||||||
| 01/09/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 57 | 70 | $30,637 | $6,525 |
| 2022 | 11 | 224 | 239 | $58,430 | $12,715 |
| 2021 | 20 | 832 | 936 | $354,183 | $81,779 |
| 2020 | 23 | 730 | 2,215 | $332,740 | $77,412 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $13,692 | $3,081 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 18 | $8,135 | $1,735 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 28 | $8,810 | $1,708 | 19.4% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2022 | 11 | 11 | $9,350 | $2,547 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 41 | $6,843 | $1,910 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 15 | $5,307 | $1,824 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $6,484 | $1,691 | 26.1% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2022 | 11 | 11 | $6,446 | $1,633 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 19 | $5,144 | $1,357 | 26.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 24 | 25 | $1,750 | $678.76 | 38.8% |
| 51701 | Insertion of temporary bladder tube | Office | 2022 | 16 | 16 | $2,736 | $447.10 | 16.3% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2022 | 11 | 11 | $5,500 | $265.39 | 4.8% |
| 51741 | Electronic assessment of bladder emptying | Office | 2022 | 34 | 40 | $8,600 | $257.66 | 3.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 29 | 30 | $270.00 | $104.22 | 38.6% |
| 51729 | Complex measurement of pressure of urine flow in bladder (cystometrogram) with bladder canal (urethra) pressure and voiding pressure studies | Office | 2021 | 57 | 57 | $48,450 | $15,806 | 32.6% |
| 57425 | Surgical vaginal defect repair using an endoscope | Facility | 2021 | 14 | 15 | $43,125 | $8,841 | 20.5% |
| 51797 | Insertion of device into the abdomen with measurement of pressure and urine flow rate | Office | 2021 | 53 | 53 | $31,058 | $7,430 | 23.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 42 | 42 | $17,052 | $6,907 | 40.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 91 | 113 | $17,628 | $6,780 | 38.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 52 | 52 | $16,276 | $6,331 | 38.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 55 | $11,880 | $5,214 | 43.9% |
| 57288 | Creation of sling around bladder canal (urethra) to control leakage | Facility | 2021 | 16 | 16 | $25,200 | $5,035 | 20.0% |
| 58260 | Vaginal removal of uterus (250 grams or less) | Facility | 2021 | 13 | 13 | $23,140 | $4,439 | 19.2% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 18 | 22 | $11,352 | $3,329 | 29.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 20 | $5,860 | $2,654 | 45.3% |
About Dr. Michael Heit, MD
Dr. Michael Heit, MD is a Urogynecology and Reconstructive Pelvic Surgery healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336143031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Heit, MD has received a total of $445.88 in payments from pharmaceutical and medical device companies, with $19.88 received in 2022. These payments were reported across 15 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($321.88).
As a Medicare-enrolled provider, Heit has provided services to 1,843 Medicare beneficiaries, totaling 3,460 services with total Medicare billing of $178,431. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Urogynecology and Reconstructive Pelvic Surgery
- Other Specialties Gynecology, Obstetrics & Gynecology
- Location Indianapolis, IN
- Active Since 06/09/2005
- Last Updated 08/11/2022
- Taxonomy Code 207VF0040X
- Entity Type Individual
- NPI Number 1336143031
Products in Payments
- Myrbetriq (Drug) $124.36
- GENERAL - FEMALE SUI (Device) $124.00
- SOLYX (Device) $61.06
- ESTRACE CREAM (Drug) $41.20
- GENERAL FEMALE SUI (Device) $36.15
- CitraNatal (Drug) $20.98
- SUTAB (Drug) $19.88
- LO LOESTRIN FE (Drug) $18.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urogynecology and Reconstructive Pelvic Surgery Doctors in Indianapolis
Douglass Hale, Md, MD
Urogynecology and Reconstructive Pelvic Surgery — Payments: $801.26
Amanda Chapa, Md, Mph, MD, MPH
Urogynecology and Reconstructive Pelvic Surgery — Payments: $287.77